Anna Fleischer is a Clinician Scientist and Assistant Doctor at the University Hospital Würzburg, Department of Internal Medicine II, specializing in psychosomatic medicine and innovative myeloma therapy. She holds a Dr. med., a Master of Science in Translational Medicine, and a Master of Health Business Administration, reflecting her strong integration of clinical care, translational research, and healthcare leadership. She is the inventor and project leader of the ENDOLEASE platform, a biodegradable intra-arterial drug delivery system designed to enhance therapeutic precision and efficacy, and also leads GUSTABOR, a digital companion for taste-related supportive care in oncology, alongside multiple completed and ongoing projects in multiple myeloma and CAR-T cell therapy. Her research interests focus on patient involvement, side-effects management, digitalization, and improving therapeutic outcomes across oncology, cardiology, and neurology. Dr. Fleischer has received numerous honors, including the Medical Valley Award and the Bätz-Preis, and is an elected member of Sigma Xi, The Scientific Research Honor Society, recognized for outstanding research achievements. She actively collaborates with industry and academic partners such as BioM, IGZ Würzburg, and MIT/Harvard, and is an inventor on an internationally published patent for endovascular drug delivery owned by the University of Würzburg. Her scholarly impact is reflected in an h-index of 6, with 13 documents receiving 79 citations, underscoring her growing influence in translational and clinical research.